S – Situation:
96 y.o. female from SNF with PMHx of dementia, HFpEF due to TTR cardiac amyloidosis, pulmonary hypertension, HTN, HLD, A-fib, SSS s/p PPM, CKD 3B, urinary retention with chronic Foley, gout, hypothyroidism, and DM.
Admitted on 10/8 for rhinovirus infection and HFpEF exacerbation.
Patient is AOx1, on room air, bedrest, no code / DNR–DNI.
Currently c/o intermittent chest pain and altered mental status.
B – Background:
Recent CXR shows prominent interstitial markings and bibasilar opacities consistent with infection vs. pulmonary edema.
ProBNP elevated at 40,000 (prior ≤25,000), HS troponin 80→93→90 (no significant EKG changes).
Procalcitonin negative. RVP positive for rhinovirus. Weight up ~10 lbs (possibly inaccurate).
Urine culture growing Klebsiella, pan-sensitive.
Foley catheter in place for chronic urinary retention; I&O monitored strictly.
IV access: Left forearm #20G.
A – Assessment:
-
Respiratory: On RA, no SOB. +JVD, +BLE edema → volume overload suspected.
-
Cardiac: HFpEF exacerbation; hemodynamically stable.
-
GU: Chronic Foley, pyuria present; UA difficult to interpret due to indwelling catheter.
-
GI: BM today.
-
Neuro: Dementia, AOx1 at baseline.
-
Renal: CKD4, Cr stable at baseline.
-
Skin: Intact.
-
Mobility/Nutrition: Bedrest; 1:1 feeder; cardiac consistent carbohydrate diet.
-
Mood: Calm; occasionally confused.
-
Comorbidities:
-
Acute on chronic HFpEF (EF 55% on 7/10/2025)
-
Immunosuppressed due to chronic prednisone
-
Hypercoagulable state (A-fib)
-
PMH COVID
-
Secondary: Hypocalcemia
-
R – Recommendation / Plan:
-
Rhinovirus / HFpEF exacerbation:
-
Continue Hydralazine 50 mg
-
Resume home dose Bumex 2 mg PO BID
-
Metolazone 5 mg BID today to augment diuresis
-
Monitor lytes, Cr, I/O, daily weight
-
-
Pyuria / Chronic Foley:
-
Continue Foley care
-
Follow up urine cultures
-
Started on Ceftriaxone 10/11 for Klebsiella (pan-sensitive)
-
-
CKD4:
-
Monitor renal function closely with diuresis
-
-
Gout:
-
Continue prednisone 5 mg daily
-
Continue allopurinol
-
-
Hypothyroidism:
-
Continue levothyroxine
-
-
Mood disorder:
-
Continue mirtazapine
-
-
Other:
-
VTE prophylaxis: apixaban (Eliquis) 2.5 mg
-
Diet: Cardiac consistent carbohydrate
-
Continue to monitor for respiratory distress, worsening edema, or chest discomfort.
-
Maintain bedrest, assist with ADLs, ensure safety measures.
-
78 y.o. male with PMHx s/f dementia, CAD, COPD, HTN, and severe malnutrition, who presented with progressive dementia and behavioral disturbances, initially felt to be secondary to UTI, now s/p 5-day course of antibiotics. Currently awaiting conservatorship (of finance) and T19.
Plan:
-
# Dementia w/ Behavioral Disturbance
-
Continue olanzapine 5 mg at 6 pm (with melatonin and trazodone 50 mg at 8 pm)
-
Trazodone 25 mg TID PRN for agitation
-
-
# Fungal Rash (hips)
-
Continue clotrimazole BID x 2 weeks
-
Chronic/Stable Issues:
-
CAD – Continue aspirin, statin
-
Severe malnutrition – Continue thiamine, folic acid, MV, Ensure TID
-
COPD – Continue Stiolto
-
Orthostatic hypotension – Continue midodrine 2.5 mg TID (consider holding; monitor BP)
-
BPH – Continue Flomax
Comorbidities on Admission: Chronic anemia
Additional Findings: Patient reports food insecurity
Diet: Regular, with nutritional supplements
VTE PPx: Enoxaparin 40 mg SC daily
Medication Reconciliation: Partially complete
Communication: RN and Case Management
Discharge Readiness:
-
Expected Discharge Date: 10/28/25
-
AM-PAC (RN/PT): 15 / 16
-
Expected Disposition: Long-Term Care
-
Barrier(s): Pending T19 approval
-
Code Status: Full Code
Patient 2:
89 y.o. female with PMHx s/f dementia c/b behavioral disturbance, HTN/HLD, HFrEF, CKD3b, TIA, and recurrent UTIs, who presented with increased confusion, agitation, and combativeness following loss of 24h home aide.
Plan:
-
Dementia w/ Behavioral Disturbance
-
Geriatrics consulted for medication management
-
Continue home Seroquel 25 mg qhs
-
Continue home risperidone 0.25 mg at 7 am and 0.5 mg at 3 pm
-
Continue Lexapro (in place of home Celexa)
-
Geriatrics recommendations for agitation:
-
Atarax 25 mg TID PRN anxiety
-
Seroquel 25–50 mg TID PRN
-
Risperdal 0.25 mg ODT BID PRN if unable to swallow/psychosis
-
Zyprexa 2.5 mg IV/IM for acute safety threat (may repeat in 30 min if ineffective)
-
-
-
# Hypothyroidism
-
TSH elevated with low FT4; patient nonadherent at home
-
Continue Synthroid 112 mcg daily
-
Repeat TSH in 4–6 weeks
-
-
Hypertension
-
Continue losartan 100 mg daily (replacing home olmesartan 40 mg)
-
-
Recurrent UTIs / Asymptomatic Bacteriuria
-
Hold antibiotics per ID (likely colonization)
-
Consider methenamine + vitamin C to acidify urine
-
-
Hypercalcemia (chronic)
-
iCal 5.50, PTH mildly elevated (possible primary hyperparathyroidism)
-
Monitor
-
Comorbidities on Admission:
-
Chronic HFrEF (EF 29%, 12/30/24)
-
Thrombocytopenia
-
Chronic anemia
-
PMH of COVID
Secondary Diagnoses: Hypercalcemia, Thrombocytopenia
Diet: Regular with nutritional supplements
VTE PPx: Enoxaparin 40 mg SC daily
Medication Reconciliation: Partially complete
Communication: RN and Case Management
Discharge Readiness:
-
Expected Discharge Date: 10/13/25
-
AM-PAC (RN/PT): 15 / —
-
Expected Disposition: Undetermined
-
Barrier(s): Behavioral improvement and safe dispo plan
-
Code Status: Full Code
Patient 3:
54 y.o. female recently released from jail with history of polysubstance use (OUD, cocaine), PTSD, who presented with fever and back pain after IVDU; found to have Serratia marcescens bacteremia.
Findings:
MRI spine → discitis/OM L4–S1 with ventral epidural and psoas phlegmon; severe spinal stenosis. No drainable collection.
Plan:
-
# Serratia marcescens bacteremia / Discitis / Epidural Phlegmon
-
Continue ceftriaxone x6 weeks (EOT ~11/6/25)
-
ID & neurosurgery following
-
PICC deferred d/t recurrent fevers
-
Continue pain management (oxycodone, lidocaine patch, Tylenol, PRN Flexeril/Motrin, gabapentin)
-
Workup for noninfectious fever ongoing (CT A/P, TTE, cortisol, D-dimer all non-revealing)
-
-
# Polysubstance Use Disorder / IVDU
-
Utox + for fentanyl, cannabinoids
-
Started on suboxone; addiction medicine following for placement
-
Diet: Regular
Medication Reconciliation: Partially complete
Communication: RN, ID, Addiction Medicine
Patient 4:
73 y.o. female with dementia (nonverbal baseline), seizures, SDH (burr hole), OSA (CPAP), Afib (not on AC), and HTN, admitted with weakness and lethargy → septic shock (UTI vs CAP) → required pressors and intubation (extubated 9/26).
Plan:
-
# CAP vs UTI (resolved)
-
Completed Zosyn x7d
-
Hemodynamically stable; pancytopenia resolved
-
-
# Dysphagia, Severe Malnutrition
-
NG feeds continued; encourage PO intake as tolerated
-
Family declined G-tube; FULL CODE; CPAP even during naps to reduce hypercarbia
-
Maintain NG feeds; encourage oral feeding when alert
-
-
# Encephalopathy
-
At baseline severe dementia; intermittently follows commands, nonverbal
-
-
Chronic Issues:
-
OSA on CPAP nightly and during naps
-
Seizure disorder – continue Keppra
-
Afib – on ASA only
-
HTN – continue losartan
-
Dispo: Pending improved oral nutrition; may need renewed GOC if no progress
Code Status: Full Code
Patient 5:
61 y.o. male with Afib (on Eliquis), CVA/TIA, T2DM, AUD, s/p R BKA, and MDD, who presented after suicide attempt via gabapentin overdose (now cleared by psych). Course notable for intractable hiccups (resolved) and bowel/bladder incontinence (improved). Now medically stable; awaiting conservatorship/T19 for safe dispo.
Plan:
-
# FTT / Mild Cognitive Impairment / MDD (hx SI)
-
Continue Cymbalta 20 mg daily
-
Cleared by psych; lacks capacity → cannot leave AMA
-
Undergoing conservatorship/T19 for STR vs LTC
-
Referral to Adler Center at discharge
-
-
# Lower Back Pain (MSK)
-
Continue multimodal pain regimen (APAP, Flexeril PRN, lidocaine patch, heat)
-
Avoid NSAIDs while on anticoagulants
-
-
# Splenic Infarct (incidental)
-
Continue Eliquis + Plavix
-
Heme signed off
-
-
# DM2
-
A1c 7.0 (9/25/25)
-
Continue linagliptin 5 mg daily; ISS low dose
-
Monitor diet adherence; adjust if glucose >180
-
-
# Chronic Conditions
-
RLS – continue ropinirole 4 mg qhs
-
HTN/Afib/CVA – continue Eliquis, Plavix, metoprolol 25 mg, amlodipine 10 mg, statin
-
Chronic LBP – continue buprenorphine and acetaminophen
-
Comorbidities on Admission: Transportation insecurity
Secondary Diagnoses: Hypokalemia, Hypomagnesemia, Hyponatremia, DM with hyperglycemia
Diet: Regular
VTE PPx: Apixaban 5 mg
Medication Reconciliation: Partially complete
Communication: RN and Case Management
Discharge Readiness:
-
Expected Discharge Date: 10/24/25
-
AM-PAC (RN/PT): 14 / 12
-
PT Dispo: Moderate complexity (10/9/2)
-
Expected Location: TBD (awaiting conservatorship)
-
Code Status: Full Code
No comments:
Post a Comment